Park; Tae Kyo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Tae Kyo.The latest application filed is for "compounds comprising self-immolative group".

Company Profile

4.28.28

Park; Tae Kyo - Daejeon KR
Park; Tae-Kyo - Deajeon N/A KR
Park, Tae-Kyo - Taejon KR
Park; Tae Kyo - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compound bearing beta-galactoside-introduced self-immolative linker Grant 11,065,343 - Park , et al. July 20, 2	2021-07-20
Compounds comprising self-immolative group Grant 10,980,890 - Kim , et al. April 20, 2	2021-04-20
Compounds Comprising Self-immolative Group App 20200069816 - Kim; Yong Zu ; et al.	2020-03-05
Compound Bearing Beta-Galactoside-Introduced Self-Immolative Linker App 20190328902 - Park; Tae Kyo ; et al.	2019-10-31
Compounds comprising self-immolative group Grant 10,383,949 - Kim , et al. A	2019-08-20
Compounds Comprising Self-immolative Group App 20180353611 - Kim; Yong Zu ; et al.	2018-12-13
Compounds comprising self-immolative group Grant 9,993,568 - Kim , et al. June 12, 2	2018-06-12
Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-- 1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same Grant 9,988,372 - Choi , et al. June 5, 2	2018-06-05
Compounds comprising self-immolative group Grant 9,919,057 - Kim , et al. March 20, 2	2018-03-20
Antibody-active Agent Conjugates And Methods Of Use App 20180021451 - Kim; Yong Zu ; et al.	2018-01-25
Novel Crystalline Form Of 5-chloro-n-(methyl)thiophene-2-carboxamide Methanesulfonate And Pharmaceutical Composition Comprising Same App 20170152251 - CHOI; Soongyu ; et al.	2017-06-01
Cephalosporin derivatives and pharmaceutical compositions thereof Grant 9,630,977 - Cho , et al. April 25, 2	2017-04-25
Compounds Comprising Self-immolative Group App 20170095576 - Kim; Yong Zu ; et al.	2017-04-06
Protein-active Agent Conjugates And Methods Of Use App 20160213786 - Kim; Yong Zu ; et al.	2016-07-28
Compounds Comprising Self-immolative Group App 20160184451 - Kim; Yong Zu ; et al.	2016-06-30
Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same Grant 9,062,066 - Yang , et al. June 23, 2	2015-06-23
Oxazolidinone derivative and medical composition containing same Grant 8,846,669 - Cho , et al. September 30, 2	2014-09-30
Heterocyclic compound, and composition for treating inflammatory diseases using same Grant 8,809,541 - Gwak , et al. August 19, 2	2014-08-19
Novel Oxazolidinone Derivative And Medical Composition Containing Same App 20140179691 - Cho; Young Lag ; et al.	2014-06-26
Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-- 1,3-oxazolidin-5-yl}methyl) derivative and intermediate used therein Grant 8,754,210 - Cho , et al. June 17, 2	2014-06-17
Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-- (substituted methyl)oxazolidin-2-one derivatives Grant 8,703,939 - Cho , et al. April 22, 2	2014-04-22
Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxoo- xazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives Grant 8,637,667 - Cho , et al. January 28, 2	2014-01-28
Novel Cephalosporin Derivatives And Pharmaceutical Compositions Thereof App 20130178455 - Cho; Young Lag ; et al.	2013-07-11
Novel Heterocyclic Compound, And Composition For Treating Inflammatory Diseases Using Same App 20130165652 - Gwak; Hyung Sub ; et al.	2013-06-27
Novel Heterocyclic Compound, And Composition For Treating Inflammatory Diseases Using Same App 20130158047 - Gwak; Hyung Sub ; et al.	2013-06-20
Anti-inflammatory Compound Having Inhibitory Activity Against Multiple Tyrosine Kinases And Pharmaceutical Composition Containing Same App 20130072482 - Yang; Beom-Seok ; et al.	2013-03-21
Method For Preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-- (substituted Methyl)oxazolidin-2-one Derivatives App 20130005967 - Cho; Young Lag ; et al.	2013-01-03
Cephalosporin derivatives and pharmaceutical compositions thereof Grant 8,329,684 - Cho , et al. December 11, 2	2012-12-11
Novel Cephalosporin Derivatives And Pharmaceutical Compositions Thereof App 20120264727 - CHO; Young Lag ; et al.	2012-10-18
FXa inhibitors with cyclic amidines as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof Grant 8,288,423 - Cho , et al. October 16, 2	2012-10-16
Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof Grant 8,242,113 - Cho , et al. August 14, 2	2012-08-14
Method For Preparing 5-chloro-n-(methyl)thiophen-2-carboxamide Derivative And Intermediate Used Therein App 20120136149 - Cho; Young Lag ; et al.	2012-05-31
FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof Grant 8,178,525 - Song , et al. May 15, 2	2012-05-15
Method For Preparing (s)-5-chloro-n-((3-(4-(5,6-dihydro-4h-1,2,4-oxadiazin-3-yl)phenyl)-2-oxoo- Xazolidin-5-yl)methyl)thiophene-2-carboxamide Derivatives App 20120108808 - Cho; Young Lag ; et al.	2012-05-03
Novel Oxazolidinone Derivatives with Cyclic Amidoxime or Cyclic Amidrazone and Pharmaceutical Compositions Thereof App 20110178293 - Cho; Young Lag ; et al.	2011-07-21
Fxa Inhibitors With Cyclic Amidoxime Or Cyclic Amidrazone As P4 Subunit, Processes For Their Preparations, And Pharmaceutical Compositions And Derivatives Thereof App 20110112083 - Song; Ho Young ; et al.	2011-05-12
Fxa Inhibitors With Cyclic Amidines As P4 Subunit, Processes For Their Preparations, And Pharmaceutical Compositions And Derivatives Thereof App 20100184781 - Cho; Young Lag ; et al.	2010-07-22
Caspase inhibitors containing isoxazoline ring Grant 7,557,133 - Chang , et al. July 7, 2	2009-07-07
Caspase inhibitors containing isoxazoline ring App 20060223848 - Chang; Hye-Kyung ; et al.	2006-10-05
Isoxazoline derivative and a process for the preparation thereof Grant 6,747,050 - Kim , et al. June 8, 2	2004-06-08
Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof App 20030065176 - Kang, Myung-Gyun ; et al.	2003-04-03
Colon cancer KH-1 and N3 antigens App 20020006900 - Danishefsky, Samuel J. ; et al.	2002-01-17
Colon cancer KH-1 and N3 antigens Grant 6,238,668 - Danishefsky , et al. May 29, 2	2001-05-29
Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof Grant 6,090,789 - Danishefsky , et al. July 18, 2	2000-07-18
Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof Grant 5,708,163 - Danishefsky , et al. January 13, 1	1998-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.